Recipharm has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.
Recipharm, contract development and manufacturing organization (CDMO), has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.
ISO 45001 is the new working protection standard from the International Organization for Standardization (ISO), which was developed to improve employee safety, reduce workplace risk, and create better working conditions globally. The certification has been developed from an earlier one according to OSHAS 18001.
“Recipharm is committed to the ongoing development of its sustainability standards,” said Erik Haeffler, VP of Manufacturing Services and head of sustainability, in a Feb. 28, 2019 press release. “Achieving ISO 45001 at our first site demonstrates that we can perform to the highest standards when it comes to occupational health and safety. We now start the roll-out across our other facilities as we work towards ensuring we have management systems in place to manage not only occupational health and safety, but also other areas such as the environmental impact.”
Source: Recipharm
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.